Tony Ho - VP at AstraZeneca to speak at Pain Therapeutics Conference Sept 13-14, San Francisco, CA
Tony W. Ho, Vice President of Clinical New Opportunities iMED at AstraZeneca will give a featured presentation entitled "From Withdrawal to Connoisseur: Efficient Pathway to POC in Pain" at the Pain Research and Therapeutics Conference taking place on Sept 13-14, 2012 in San Francisco, CA.
- (1888PressRelease) July 21, 2012 - Tony W. Ho, Vice President of Clinical New Opportunities iMED at AstraZeneca will give a featured presentation entitled, "From Withdrawal to Connoisseur: Efficient Pathway to POC in Pain" at the Pain Research and Therapeutics Conference taking place on Sept 13-14, 2012 in San Francisco, CA.
Tony is responsible for the reposition and development of AstraZeneca assets, in licensing of novel compounds. Some of his recent efforts include MRC/Astrzeneca and NIH NCAT initiative.
GTC's Pain Research and Therapeutics Conference will discuss the latest hot topics including, new drug targets, therapeutic approaches, preclinical and clinical development, animal models, beyond traditional opioids, overcoming challenges in pain therapeutics, and much more.
Network with key representatives in the field including Charles B. Nemeroff at University of Miami, Stephen Brannan - VP at Takeda, Husseini Manji - Global Head of Neuroscience Therapeutic at Janssen, Barry Brand - Chief Executive Officer at CeNeRx, David Shelton at Pfizer, George Garibaldi - Global Head of CNS Clinical Development at F. Hoffmann-La Roche, Michael C. Venuti - CSO at NeuroTherapeutics, and many more!
For more information, please visit www.gtcbio.com
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam